[PDF] Top 20 Manual de Productos de Aprendizaje Trabajos Independientes[1]

... the new technologies that have identi- fied potential next-generation biomarkers ...risk lung cancer patients ...two new proteins, PTRF/cavin-1 and MIF, as potential therapeutic targets ... See full document

... Important prerequisites to SSTR-targeted therapy are a robust expression of as well as a specific binding to the target receptor. We could demonstrate a good correlation between imaging results and histopathological ... See full document

... A total of 11 publications met the criteria for this analysis [10-20] (Figure 1). The total num- ber of patients was 1004, ranging from 50 to 161 patients per study. Main characteristics of the eligible studies were ... See full document

... breast cancer (score 0, no staining observed or incomplete faint/barely perceptible cytoplasmic staining of <10% of tumour cells; score 1, incomplete faint/barely percep- tible cytoplasmic staining of >10% ... See full document

... Our findings have several potential implications. First, we have shown that a combined increase in the levels of HMGB1, PDMP, and PAI-1 is related to NSCLC prognosis. Second, we have described how vascular complications ... See full document

... Results: Final analysis of 1,872 NSCLC patients from 19 eligible studies was performed. We observed that CXCR4 expression was significantly higher in NSCLC than in normal lung tissue, based on the pooled OR from ... See full document

... Among our eligible studies, four [24, 25, 33, 34] reported statistics for DFS and three [22, 26, 30] for PFS. Most of the patients in such studies had undergone surgical resection. Yoo S.B. et al. [26] reported a cohort ... See full document

... shown in the survival outcome with the addition of vismo- degib to standard chemotherapy, and the authors concluded that further evaluation of hedgehog inhibitors with chemo- therapy could not be recommended for patients ... See full document

... as cell free DNA (cfDNA) is a potential marker which was discovered in 1948 by Mandel and ...in cancer patients was published in the seventies ...in cancer patients has been in- vestigated in ... See full document

... squamous cell carcinoma or adenocarcinoma by pathology; 2) patients were diagnosed with stage I–IIIa NSCLC, according to the TNM staging system summarized by the International Union Against Cancer (2009) 4 ... See full document

... 365 lung cancers and 30 normal lung ...or non-tumorous ...a new blank recipient paraffin block (35 mm × 22 mm × 5 mm) with a commercially available microarray instrument (Beecher Instruments, ... See full document

... The randomized Phase III First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never- Smokers With Adenocarcinoma of the Lung (First-SIGNAL) trial enrolled 313 Korean never-smokers with advanced ... See full document

... . NKX2–1 gene amplification displayed a positive cor- relation with the presence of KRAS mutations; however, its prognostic impact remains controversial. In a Japa- nese ADK cohort, NKX2–1 amplification was an ... See full document

... well-known prognostic marker of non-small cell lung cancer (NSCLC), serum CEA concentration has been reported to be affected by smoking status and body mass index ... See full document

... unfavorable prognostic factor in NSCLC overall survival is a unique and practical diagnostic tool to determine prognosis in ...ful marker for the diagnosis of NSCLC by ELISA tech- ... See full document

... of lung cancer patients is still controversial ...primary non-small cell lung caner has a potential role as a prognostic factor ... See full document

... subtypes lung adenocarcinomas and squamous cell carcinomas found a higher rate of mutations in these cancers than acute myelogenous leukemia, glioblastoma multiforme, and cancers of the breast, ovaries, and ... See full document

... in cancer patients [1, ...melanoma cell line in 1988 by ...breast cancer, and melanoma cells reduced their invasiveness and metastatic potential in vivo ... See full document

... Circulating cell-free DNA (cfDNA), which can be obtained from plasma or serum by non-invasive procedures, has showed great potential to predict treatment response and survival for cancer ...the ... See full document

... This study has some limitations, which have to be presented. Firstly, some diabetes mellitus-related factors were not collected completely in this retrospective study. Secondly, the patient size in our study was ... See full document